← TrialMatch
HomeTrials

Physical Inactivity and Appetite Regulation

The goal of this parallel-group, two-arm, assessor-blinded, randomised clinical trial is to investigate the effects of reducing physical activity on food intake and satiety in physically active and healthy males, 40-55 years of age. The main questions it aims to answer are: * Does physical inactivity affect GLP-1 stimu

Condition(s)Overweight
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe goal of this parallel-group, two-arm, assessor-blinded, randomised clinical trial is to investigate the effects of reducing physical activity on food intake and satiety in physically active and healthy males, 40-55 years of age. The main questions it aims to answer are: * Does physical inactivity affect GLP-1 stimulated food intake? * Does physical inactivity affect food preferences, satiety and other mechanisms supporting appetite regulation? Participants will be randomised (1:1) to two weeks of either no intervention (control group) or inactivity. Inactivity will be implemented as cessation of active commuting and all other structured exercise. Furthermore, steps will be reduced to a maximum of 1500 steps/day. Researchers will compare the inactivity group to the control group to see
Who can participateInclusion Criteria: 1. Male 2. Age ≥ 40 years and ≤ 55 years 3. Body mass index (BMI) \> 20 and \< 25 kg/m2 4. Physical activity level should as a minimum include: Active commuting by biking a minimum of 10 km, four days per week or an equivalent amount of other physical activity four days per week. 5. Healthy (based on self-reporting, pre-study medical examination and biochemical screening) 6. Can adhere to two weeks of inactivity (refrain from running, cycling and all other exercise while reducing steps to max. 1500 pr. day) 7. Caucasian 8. No change in body weight \> 5 kg within the last 6 months 9. Eats breakfast and lunch daily 10. Does not follow specific dietary restrictions 11. No disliking of spaghetti bolognese 12. No diagnosis of psychiatric disorder or treatment with anti-depre
Ages40 Years to 55 Years
SexMale
Accepts healthy volunteersYes
Lead sponsorRigshospitalet, Denmark
LocationsCopenhagen, Denmark
Start date2024-03-01
NCT IDNCT06240208
Official listinghttps://clinicaltrials.gov/study/NCT06240208

🔍 Search all trials →